Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome
SciSparc secures FDA approval for Phase IIb clinical trial of SCI-110, targeting unmet needs in Tourette Syndrome, Global trial begins soon.
Produce Blue Book21m
Produce Distributors Association provides FSMA 204 guidance
The complexities of FSMA 204(d) prompted the session to concentrate on distributors, who are scrambling to both try to understand the nuances of the Food Traceability Final Rule.
RMTC Develops Withdrawal Guidance For DMSO, Pentosan
The RMTC is working to provide horsemen and veterinarians with scientifically-derived information to promote compliance with ...
Altria Group, Inc. (MO): Resilient Tobacco Business and Growth in Smoke-Free Products
For this list, we looked at a group of over 150 dividend champions, which are known for raising dividends for 25 years or ...
FDA approves new drug for treatment of schizophrenia
The U.S. Food and Drug Administration approved a new drug for the treatment of schizophrenia in adults. Dr. Darien Sutton explains.
Emergency Doctor Worries Louisiana’s New Classification for Abortion Meds Could Be Life-Threatening
A new law will go into effect in Louisiana on Oct. 1 that will classify two drugs—mifepristone and misoprostol, which are ...
Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate
On Friday, Aquestive Therapeutics, Inc. (NASDAQ:AQST) hosted a virtual investor day highlighting the company’s Anaphylm ...